Filing Details
- Accession Number:
- 0001140361-23-022963
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-04 16:15:52
- Reporting Period:
- 2023-05-02
- Accepted Time:
- 2023-05-04 16:15:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 9326 | Balchem Corp | BCPC | Chemicals & Allied Products (2800) | 132578432 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1906436 | Robert Michael Sestrick | C/O Balchem Corporation 5 Paragon Drive Montvale NJ 07645 | Svp & Chief Technology Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-05-02 | 2,300 | $130.36 | 5,424 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiples sales ranging from $129.9700 to $130.9000 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
- Includes acquisition of shares under the Balchem Corporation 401(k) plan.
Billionaire Hedge Funds
